The binding of vinca domain agents to tubulin: Structural and biochemical studies

Methods in Cell Biology

Volumn 95, Issue C, 2010, Pages 373-390

  Cormier, Anthony ^a,b   Knossow, Marcel ^a   Wang, Chunguang ^c   Gigant, Benoît ^a  

^a LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; TUBULIN; VINCA ALKALOID;

ANIMAL; BIOCHEMISTRY; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; BIOCHEMISTRY; FLUORESCENT DYES; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; VINCA ALKALOIDS;

EID: 77955289715     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0091-679X(10)95020-6     Document Type: Book

References (43)

1. Alday, P. H., and Correia, J. J. (2009). Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation. Biochemistry 48, 7927-7938.
2. Amayed, P., Carlier, M. F., and Pantaloni, D. (2000). Stathmin slows down guanosine diphosphate dissociation from tubulin in a phosphorylation-controlled fashion. Biochemistry 39, 12295-12302.
3. Amos, L. A., Jubb, J. S., Henderson, R., and Vigers, G. (1984). Arrangement of protofilaments in two forms of tubulin crystal induced by vinblastine. J. Mol. Biol. 178, 711-729.
4. Bai, R. L., Pettit, G. R., and Hamel, E. (1990). Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J. Biol. Chem. 265, 17141-17149.
5. Barbier, P., Gregoire, C., Devred, F., Sarrazin, M., and Peyrot, V. (2001). In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: Molecular modeling of the mechanism of action of a new antimitotic drug. Biochemistry 40, 13510-13519.
6. Brannstrom, K., Segerman, B., and Gullberg, M. (2003). Molecular dissection of GTP exchange and hydrolysis within the ternary complex of tubulin heterodimers and Op18/stathmin family members. J. Biol. Chem. 278, 16651-16657.
7. Caplow, M., and Zeeberg, B. (1980). Stoichiometry for guanine nucleotide binding to tubulin under polymerizing and nonpolymerizing conditions. Arch. Biochem. Biophys. 203, 404-411.
8. Clément, M.-J., Jourdain, I., Lachkar, S., Savarin, P., Gigant, B., Knossow, M., Toma, F., Sobel, A., and Curmi, P. A. (2005). N-terminal Stathmin-like peptides bind tubulin and impede microtubule assembly. Biochemistry 44, 14616-14625.
9. Cormier, A., Clement, M. J., Knossow, M., Lachkar, S., Savarin, P., Toma, F., Sobel, A., Gigant, B., and Curmi, P. A. (2009). The PN2-3 domain of CPAP implements a novel mechanism for tubulin sequestration. J. Biol. Chem. 284, 6909-6917.
10. Cormier, A., Marchand, M., Ravelli, R. B., Knossow, M., and Gigant, B. (2008). Structural insight into the inhibition of tubulin by vinca domain peptide ligands. EMBO Rep. 9, 1101-1106.
11. Correia, J. J., Baty, L. T., andWilliams, R. C., Jr. (1987). Mg2+ dependence of guanine nucleotide binding to tubulin. J. Biol. Chem. 262, 17278-17284.
12. Curmi, P. A., Gavet, O., Charbaut, E., Ozon, S., Lachkar-Colmerauer, S., Manceau, V., Siavoshian, S., Maucuer, A., and Sobel, A. (1999). Stathmin and its phosphoprotein family: General properties, biochemical and functional interaction with tubulin. Cell Struct. Funct. 24, 345-357.
13. Dabydeen, D. A., Burnett, J. C., Bai, R., Verdier-Pinard, P., Hickford, S. J., Pettit, G. R., Blunt, J. W., Munro, M. H., Gussio, R., and Hamel, E. (2006). Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin. Mol. Pharmacol. 70, 1866-1875.
14. David-Pfeuty, T., Simon, C., and Pantaloni, D. (1979). Effect of antimitotic drugs on tubulin GTPase activity and self-assembly. J. Biol. Chem. 254, 11696-11702.
15. Devred, F., Tsvetkov, P. O., Barbier, P., Allegro, D., Horwitz, S. B., Makarov, A. A., and Peyrot, V. (2008). Stathmin/Op18 is a novel mediator of vinblastine activity. FEBS Lett. 582, 2484-2488.
16. Dorléans, A., Gigant, B., Ravelli, R. B., Mailliet, P., Mikol, V., and Knossow, M. (2009). Variations in the colchicine-binding domain provide insight into the structural switch of tubulin. Proc. Natl. Acad. Sci. U.S.A. 106, 13775-13779.
17. Dorléans, A., Knossow, M., and Gigant, B. (2007). Studying drug-tubulin interactions by X-Ray crystallography. In "Microtubule Protocols." (J. Zhou, ed.), Vol. 137, pp. 235-244. Humana Press, Totowa, NJ.
18. Ennifar, E., Carpentier, P., Ferrer, J. L., Walter, P., and Dumas, P. (2002). X-ray-induced debromination of nucleic acids at the Br K absorption edge and implications for MAD phasing. Acta Crystallogr. D Biol. Crystallogr. 58, 1262-1268.
19. Fujiwara, K., and Tilney, L. G. (1975). Substructural analysis of the microtubule and its polymorphic forms. Ann. N. Y. Acad. Sci. 253, 27-50.
20. Gigant, B., Curmi, P. A., Martin-Barbey, C., Charbaut, E., Lachkar, S., Lebeau, L., Siavoshian, S., Sobel, A., and Knossow, M. (2000). The 4Å X-ray structure of a tubulin:stathmin-like domain complex. Cell 102, 809-816.
21. Gigant, B., Wang, C., Ravelli, R. B., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A., and Knossow, M. (2005). Structural basis for the regulation of tubulin by vinblastine. Nature 435, 519-522.
22. Hamel, E. (1992). Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B. Pharmacol. Ther. 55, 31-51.
23. Heusele, C., and Carlier, M. F. (1981). GTPase activity of the tubulin-colchicine in relation with tubulin- tubulin interactions. Biochem. Biophys. Res. Commun. 103, 332-338.
24. Himes, R. H. (1991). Interactions of the catharanthus (vinca) alkaloids with tubulin and microtubules. Pharmacol. Ther. 51, 257-267.
25. Jordan, M. A., and Wilson, L. (2004). Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253-265.
26. Li, H., DeRosier, D. J., Nicholson, W. V., Nogales, E., and Downing, K. H. (2002). Microtubule structure at 8Å resolution. Structure (Camb) 10, 1317-1328.
27. Lobert, S., and Correia, J. J. (2000). Energetics of vinca alkaloid interactions with tubulin. Meth. Enzymol. 323, 77-103.
28. Mitra, A., and Sept, D. (2004). Localization of the antimitotic peptide and depsipeptide binding site on β-tubulin. Biochemistry 43, 13955-13962.
29. Nettles, J. H., Li, H., Cornett, B., Krahn, J. M., Snyder, J. P., and Downing, K. H. (2004). The binding mode of epothilone A on (,(-tubulin by electron crystallography. Science 305, 866-869.
30. Nogales, E., Wolf, S. G., and Downing, K. H. (1998). Structure of the (( tubulin dimer by electron crystallography. Nature 391, 199-203.
31. Penefsky, H. S. (1977). Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase. J. Biol. Chem. 252, 2891-2899.
32. Perez-Ramirez, B., Shearwin, K. E., and Timasheff, S. N. (1994). The colchicine-induced GTPase activity of tubulin: State of the product. Activation by microtubule-promoting cosolvents. Biochemistry 33, 6253-6261.
33. Ravelli, R. B., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., and Knossow, M. (2004). Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 428, 198-202.
34. Ravelli, R. B., Leiros, H. K., Pan, B., Caffrey, M., and McSweeney, S. (2003). Specific radiation damage can be used to solve macromolecular crystal structures. Structure (Camb) 11, 217-224.
35. Redeker, V., Lachkar, S., Siavoshian, S., Charbaut, E., Rossier, J., Sobel, A., and Curmi, P. A. (2000). Probing the native structure of stathmin and its interaction domains with tubulin. J. Biol. Chem. 275, 6841-6849.
36. Sackett, D. L. (1995). Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents. Biochemistry 34, 7010-7019.
37. Schuttelkopf, A. W., and van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355-1363.
38. Steinmetz, M. O. (2007). Structure and thermodynamics of the tubulin-stathmin interaction. J. Struct. Biol. 158, 137-147.
39. Strahs, K. R., and Sato, H. (1973). Potentiation of vinblastine crystal formation in vivo by puromycin and colcemid. Exp. Cell Res. 80, 10-14.
40. Wang, C., Cormier, A., Gigant, B., and Knossow, M. (2007). Insight into the GTPase activity of tubulin from complexes with stathmin-like domains. Biochemistry 46, 10595-10602.
41. Watts, N. R., Cheng, N.,West,W., Steven, A. C., and Sackett, D. L. (2002). The cryptophycin-tubulin ring structure indicates two points of curvature in the tubulin dimer. Biochemistry 41, 12662-12669.
42. Werbovetz, K. A., Brendle, J. J., and Sackett, D. L. (1999). Purification, characterization, and drug susceptibility of tubulin from Leishmania. Mol. Biochem. Parasitol. 98, 53-65.
43. Winn, M. D., Isupov, M. N., and Murshudov, G. N. (2001). Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D Biol. Crystallogr. 57, 122-133.